LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Bioperfectus Demonstrates Novel Infectious Disease Testing Solutions at AACC 2022

By LabMedica International staff writers
Posted on 26 Jul 2022
Print article
Image: The STC-96A and STC-96A PLUS Real-Time PCR Systems were on display at AACC 2022 (Photo courtesy of Bioperfectus)
Image: The STC-96A and STC-96A PLUS Real-Time PCR Systems were on display at AACC 2022 (Photo courtesy of Bioperfectus)

Jiangsu Bioperfectus Technologies Co., Ltd. (Shanghai, China) is demonstrating its range of molecular diagnostic instruments and testing solutions for infectious diseases at the 2022 AACC Clinical Lab Expo, including its SAW-96 and SMPE-960 nucleic acid extraction systems, alongside the STC-96A and STC-96A PLUS real-time PCR systems.

The SAW-96 automated nucleic acid extraction workstation integrates cutting-edge mechanical, electronic, and software technologies. SAW-96 integrates sample loading, nucleic acid purification, and PCR setup functions in one instrument and has typical run duration of less than 70 minutes for 1-96 samples. Based on magnetic separation technology, SAW-96 provides high throughput automation combined with high performance. The SMPE-960 nucleic acid extraction system integrates cutting-edge mechanical, electronic and software technologies to enable automated extraction of nucleic acids from samples. Featuring a modular structure, the SMPE-960 can extract nucleic acids from 1-96 samples in three independently operating modules at the same time. Each module consists of 1-32 samples so that samples can be tested upon delivery.

The STC-96A and STC-96A PLUS real-time PCR systems offer stable performance and user-friendly design for molecular laboratories to identify viral and bacterial infections. In particular, the STC-96A Plus which is designed for real-time PCR analysis of gene expression and genetic variation allows two different PCR assays to be run on just one instrument with separate-controlled programs. Both the real-time PCR systems maintain a remarkable temperature uniformity of 0.1℃ across 96 wells, ensuring highly precise diagnostic results.

AT AACC 2022, Bioperfectus is also demonstrating its wide range of testing solutions for infectious diseases, including respiratory, sexually transmitted, vector-borne, gastrointestinal, and zoonotic. Among its respiratory infectious disease tests, Bioperfectus offers the COVID-19 Coronavirus real time PCR kit, COVID-19 Coronavirus (ORF1ab/N/E) real time PCR kit, Novel Corona Virus (SARS-CoV-2) Ag rapid test kit, Novel Corona Virus (SARS-CoV-2) IgM/IgG rapid test kit, Influenza A and B Viruses real time PCR kit, and COVID-19 Coronavirus and Influenza A/B Virus real time PCR kit. For sexually transmitted diseases, Bioperfectus offers the Human Papillomavirus Genotyping real time PCR kit, Neisseria Gonorrhoeae/Chlamydia Trachomatis/U. Urealyticum real time PCR kit and Chlamydia Trachomatis real time PCR kit, among others. In zoonotic diseases, Bioperfectus has recently launched the new Monkeypox Virus real time PCR kit based on real-time PCR technology. Specific primers and probes are designed based on F3L gene areas of the Monkeypox virus. In addition, the kit also contains a housekeeping gene (RNase P) as an internal control (IC) for specimen sampling and nucleic acid extraction.
 

Related Links:
Jiangsu Bioperfectus Technologies Co., Ltd. 

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
Systemic Autoimmune Testing Assay
BioPlex 2200 ANA Screen with MDSS

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: The AI predictive model identifies the most potent cancer killing immune cells for use in immunotherapies (Photo courtesy of Shutterstock)

AI Predicts Tumor-Killing Cells with High Accuracy

Cellular immunotherapy involves extracting immune cells from a patient's tumor, potentially enhancing their cancer-fighting capabilities through engineering, and then expanding and reintroducing them into the body.... Read more

Microbiology

view channel
Image: The T-SPOT.TB test is now paired with the Auto-Pure 2400 liquid handling platform for accurate TB testing (Photo courtesy of Shutterstock)

Integrated Solution Ushers New Era of Automated Tuberculosis Testing

Tuberculosis (TB) is responsible for 1.3 million deaths every year, positioning it as one of the top killers globally due to a single infectious agent. In 2022, around 10.6 million people were diagnosed... Read more